Abstract
Increasing tensile properties and collagen content is a recognized need in articular cartilage tissue engineering. This study tested the hypothesis that multiple applications of chondroitinase ABC (CβABC), a glycosaminoglycan (GAG) degrading enzyme, could increase construct tensile properties in a scaffoldβless approach for articular cartilage tissue engineering. Developing constructs were treated with CβABC at 2 weeks, 4 weeks, or both 2 and 4 weeks. At 4 and 6 weeks, construct sulfated GAG composition, collagen composition, and compressive and tensile biomechanical properties were assessed, along with immunohistochemistry (IHC) for collagens type I, II, and VI, and the proteoglycan decorin. At 6 weeks, the tensile modulus and ultimate tensile strength of the group treated at both 2 and 4 weeks were significantly increased over controls by 78% and 64%, reaching values of 3.4 and 1.4 MPa, respectively. Collagen concentration also increased 43%. Further, groups treated at either 2 weeks or 4 weeks alone also had increased tensile stiffness compared to controls. Surprisingly, though GAG was depleted in the treated groups, by 6 weeks there were no significant differences in compressive stiffness. IHC showed abundant collagen type II and VI in all groups, with no collagen type I. Further, decorin staining was reduced following CβABC treatment, but returned during subsequent culture. The results support the use of CβABC in cartilage tissue engineering for increasing tensile properties. Β© 2009 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 27: 949β956, 2009